Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism

American Urological Association Guideline On The Management of Priapism

Drogo K. Montague, Jonathan P. Jarow, Gregory A. Broderick et al. · The Journal of Urology · 2003 · 615 citations

Medicine, Urology, Andrology +10

Priapism in sickle‐cell disease; incidence, risk factors and complications – an international multicentre study

Adebanji Adeyoju, Adebayo Olujohungbe, J.A. Morris et al. · British Journal of Urology · 2002 · 290 citations

Medicine, Genetics, Hematology +9

Phosphorylation of phosphodiesterase‐5 by cyclic nucleotide‐dependent protein kinase alters its catalytic and allosteric cGMP‐binding activities

Jackie D. Corbin, Illarion V. Turko, Alfreda Beasley et al. · European Journal of Biochemistry · 2000 · 268 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism

Hunter C. Champion, Trinity J. Bivalacqua, Eiki Takimoto et al. · Proceedings of the National Academy of Sciences · 2005 · 256 citations · Full text

Life Sciences, Physiology, Urology +14

Priapism and Impotence in Homozygous Sickle Cell Disease

Alan Emond · Archives of Internal Medicine · 1980 · 227 citations

Medicine, Hematology, Neurology +11